[Andrew_Russell]

I've been thinking about this a bit since the hearing, and here are some ideas:

- If lawyers for a defendant are going to settle (we generally prefer not to), we often want a portfolio license -- a "go away" license. By splitting up the patents among entities and keeping itself hidden, an entity like MAVEXAR can keep filing serial suits against the same targets and can keep receiving more expensive "global" settlements.

- It dodges liability for attorneys fees, since the entities have little or no money, and may decrease the chances of a fee award generally.

- It means that the entity with the patent has little or no discoverable information, decreasing the cost of suit because there is nothing to produce. Lawyers for that entity can also take stronger discovery positions because there is no concern about about responsive discovery.